Advisors Asset Management, Inc.
Position in IPSC — Century Therapeutics, Inc.
CIK 1297376
Monument, CO
Position in IPSC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,371
+$1,584 QoQ
Shares Held
8,315
+0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 98 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IPSC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $39,929,265 across 31 Biotechnology names. IPSC ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,909 | $12,869,777 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
17,228 | $5,445,598 | |
| 3 | INCY |
Incyte Corp
|
24,359 | $2,761,336 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
95,934 | $2,515,389 | |
| 5 | ASND |
Ascendis Pharma A/S
|
9,146 | $2,439,421 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
21,896 | $2,431,112 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,379 | $1,483,401 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
15,280 | $1,246,389 |
All Filings in IPSC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,371 | 8,315 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,787 | 8,313 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,271 | 8,313 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,189 | 8,412 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,750 | 8,498 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||